SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-002718
Filing Date
2014-03-20
Accepted
2014-03-20 16:24:00
Documents
17
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2219098z10-k.htm 10-K 1851543
2 EX-21.1 a2219098zex-21_1.htm EX-21.1 3533
3 EX-23.1 a2219098zex-23_1.htm EX-23.1 2983
4 EX-23.2 a2219098zex-23_2.htm EX-23.2 4347
5 EX-31.1 a2219098zex-31_1.htm EX-31.1 8090
6 EX-31.2 a2219098zex-31_2.htm EX-31.2 8059
7 EX-32.1 a2219098zex-32_1.htm EX-32.1 4681
8 EX-32.2 a2219098zex-32_2.htm EX-32.2 4407
15 G944849.JPG g944849.jpg GRAPHIC 80914
16 G268054.JPG g268054.jpg GRAPHIC 40237
17 G527675.JPG g527675.jpg GRAPHIC 59332
  Complete submission text file 0001047469-14-002718.txt   13406643

Data Files

Seq Description Document Type Size
9 EX-101.INS ontx-20131231.xml EX-101.INS 1985612
10 EX-101.SCH ontx-20131231.xsd EX-101.SCH 85623
11 EX-101.CAL ontx-20131231_cal.xml EX-101.CAL 92709
12 EX-101.DEF ontx-20131231_def.xml EX-101.DEF 393644
13 EX-101.LAB ontx-20131231_lab.xml EX-101.LAB 1359864
14 EX-101.PRE ontx-20131231_pre.xml EX-101.PRE 628688
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 14707004
SIC: 2834 Pharmaceutical Preparations